ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-18V13640
Home | Market Reports | Health| Nursing
Global LAMP Loop mediated Isothermal Amplification Technology for Respiratory Disease Market Research Report 2023
BUY CHAPTERS

Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Research Report 2024

Code: QYRE-Auto-18V13640
Report
March 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eiken Chemical
Deaou Biotechnology
Singuway
New England Biolabs
Lucigen Corporation
Merck
Mast Group
OptiGene
Weifang Kanghua Biotech Co.,Ltd

LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market

LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market

The global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease.

Report Scope

The LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Report

Report Metric Details
Report Name LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • by Pathogene
  • Mycoplasma Pneumoniae
  • Streptococcus Pneumoniae
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Chlamydia Pneumoniae
  • Klebsiella Pneumoniae
  • Staphylococcus Aureus
  • Others
  • by Disease
  • Cold
  • Pharyngitis
  • Bronchitis
  • Tracheitis
  • Pneumonia (Covid-19, CAP, etc.)
Segment by Application
  • Infant (<1 year old)
  • Children and Adolescents (1-25 years old)
  • Adult (25-65 years old)
  • Senior citizens (over 65 years old)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CapitalBio, BGI, Eiken Chemical, Deaou Biotechnology, Singuway, New England Biolabs, Lucigen Corporation, Merck, Mast Group, OptiGene, Weifang Kanghua Biotech Co.,Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market report?

Ans: The main players in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market are CapitalBio, BGI, Eiken Chemical, Deaou Biotechnology, Singuway, New England Biolabs, Lucigen Corporation, Merck, Mast Group, OptiGene, Weifang Kanghua Biotech Co.,Ltd

What are the Application segmentation covered in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market report?

Ans: The Applications covered in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market report are Infant (<1 year old), Children and Adolescents (1-25 years old), Adult (25-65 years old), Senior citizens (over 65 years old)

What are the Type segmentation covered in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market report?

Ans: The Types covered in the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market report are by Pathogene, Mycoplasma Pneumoniae, Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis, Chlamydia Pneumoniae, Klebsiella Pneumoniae, Staphylococcus Aureus, Others, by Disease, Cold, Pharyngitis, Bronchitis, Tracheitis, Pneumonia (Covid-19, CAP, etc.)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Pathogene
1.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Pathogene: 2019 VS 2023 VS 2030
1.2.2 Mycoplasma Pneumoniae
1.2.3 Streptococcus Pneumoniae
1.2.4 Haemophilus Influenzae
1.2.5 Moraxella Catarrhalis
1.2.6 Chlamydia Pneumoniae
1.2.7 Klebsiella Pneumoniae
1.2.8 Staphylococcus Aureus
1.2.9 Others
1.3 Market by Application
1.3.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infant (<1 year old)
1.3.3 Children and Adolescents (1-25 years old)
1.3.4 Adult (25-65 years old)
1.3.5 Senior citizens (over 65 years old)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Perspective (2019-2030)
2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Growth Trends by Region
2.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Region (2019-2024)
2.2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Region (2025-2030)
2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Dynamics
2.3.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Industry Trends
2.3.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers
2.3.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges
2.3.4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue
3.1.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue (2019-2024)
3.1.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Players (2019-2024)
3.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue
3.4 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio
3.4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2023
3.5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players Head office and Area Served
3.6 Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
3.7 Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Type
4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Type (2019-2024)
4.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2025-2030)
5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Application
5.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Application (2019-2024)
5.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2019-2030)
6.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024)
6.4 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2019-2030)
7.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024)
7.4 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2019-2030)
8.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2019-2030)
9.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024)
9.4 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2019-2030)
10.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CapitalBio
11.1.1 CapitalBio Company Detail
11.1.2 CapitalBio Business Overview
11.1.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.1.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.1.5 CapitalBio Recent Development
11.2 BGI
11.2.1 BGI Company Detail
11.2.2 BGI Business Overview
11.2.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.2.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.2.5 BGI Recent Development
11.3 Eiken Chemical
11.3.1 Eiken Chemical Company Detail
11.3.2 Eiken Chemical Business Overview
11.3.3 Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.3.4 Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.3.5 Eiken Chemical Recent Development
11.4 Deaou Biotechnology
11.4.1 Deaou Biotechnology Company Detail
11.4.2 Deaou Biotechnology Business Overview
11.4.3 Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.4.4 Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.4.5 Deaou Biotechnology Recent Development
11.5 Singuway
11.5.1 Singuway Company Detail
11.5.2 Singuway Business Overview
11.5.3 Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.5.4 Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.5.5 Singuway Recent Development
11.6 New England Biolabs
11.6.1 New England Biolabs Company Detail
11.6.2 New England Biolabs Business Overview
11.6.3 New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.6.4 New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.6.5 New England Biolabs Recent Development
11.7 Lucigen Corporation
11.7.1 Lucigen Corporation Company Detail
11.7.2 Lucigen Corporation Business Overview
11.7.3 Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.7.4 Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.7.5 Lucigen Corporation Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.8.4 Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Mast Group
11.9.1 Mast Group Company Detail
11.9.2 Mast Group Business Overview
11.9.3 Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.9.4 Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.9.5 Mast Group Recent Development
11.10 OptiGene
11.10.1 OptiGene Company Detail
11.10.2 OptiGene Business Overview
11.10.3 OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.10.4 OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.10.5 OptiGene Recent Development
11.11 CapitalBio
11.11.1 CapitalBio Company Detail
11.11.2 CapitalBio Business Overview
11.11.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.11.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.11.5 CapitalBio Recent Development
11.12 Weifang Kanghua Biotech Co.,Ltd
11.12.1 Weifang Kanghua Biotech Co.,Ltd Company Detail
11.12.2 Weifang Kanghua Biotech Co.,Ltd Business Overview
11.12.3 Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.12.4 Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.12.5 Weifang Kanghua Biotech Co.,Ltd Recent Development
11.13 CapitalBio
11.13.1 CapitalBio Company Detail
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.13.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.13.5 CapitalBio Recent Development
11.14 BGI
11.14.1 BGI Company Detail
11.14.2 BGI Business Overview
11.14.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.14.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
11.14.5 BGI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Eiken Chemical
Deaou Biotechnology
Singuway
New England Biolabs
Lucigen Corporation
Merck
Mast Group
OptiGene
Weifang Kanghua Biotech Co.,Ltd
List of Tables
    Table 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Mycoplasma Pneumoniae
    Table 3. Key Players of Streptococcus Pneumoniae
    Table 4. Key Players of Haemophilus Influenzae
    Table 5. Key Players of Moraxella Catarrhalis
    Table 6. Key Players of Chlamydia Pneumoniae
    Table 7. Key Players of Klebsiella Pneumoniae
    Table 8. Key Players of Staphylococcus Aureus
    Table 9. Key Players of Others
    Table 10. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2019-2024)
    Table 14. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2025-2030)
    Table 16. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Trends
    Table 17. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers
    Table 18. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges
    Table 19. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints
    Table 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players (2019-2024)
    Table 22. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2023)
    Table 23. Ranking of Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Companies by Revenue (US$ Million) in 2023
    Table 24. Global 5 Largest Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
    Table 27. Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2019-2024)
    Table 31. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2025-2030)
    Table 33. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2019-2024)
    Table 35. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2025-2030)
    Table 37. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 45. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2025-2030) & (US$ Million)
    Table 46. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 50. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 51. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 52. CapitalBio Company Detail
    Table 53. CapitalBio Business Overview
    Table 54. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 55. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 56. CapitalBio Recent Development
    Table 57. BGI Company Detail
    Table 58. BGI Business Overview
    Table 59. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 60. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 61. BGI Recent Development
    Table 62. Eiken Chemical Company Detail
    Table 63. Eiken Chemical Business Overview
    Table 64. Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 65. Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 66. Eiken Chemical Recent Development
    Table 67. Deaou Biotechnology Company Detail
    Table 68. Deaou Biotechnology Business Overview
    Table 69. Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 70. Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 71. Deaou Biotechnology Recent Development
    Table 72. Singuway Company Detail
    Table 73. Singuway Business Overview
    Table 74. Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 75. Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 76. Singuway Recent Development
    Table 77. New England Biolabs Company Detail
    Table 78. New England Biolabs Business Overview
    Table 79. New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 80. New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 81. New England Biolabs Recent Development
    Table 82. Lucigen Corporation Company Detail
    Table 83. Lucigen Corporation Business Overview
    Table 84. Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 85. Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 86. Lucigen Corporation Recent Development
    Table 87. Merck Company Detail
    Table 88. Merck Business Overview
    Table 89. Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 90. Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 91. Merck Recent Development
    Table 92. Mast Group Company Detail
    Table 93. Mast Group Business Overview
    Table 94. Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 95. Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 96. Mast Group Recent Development
    Table 97. OptiGene Company Detail
    Table 98. OptiGene Business Overview
    Table 99. OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 100. OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 101. OptiGene Recent Development
    Table 102. CapitalBio Company Detail
    Table 103. CapitalBio Business Overview
    Table 104. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 105. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 106. CapitalBio Recent Development
    Table 107. Weifang Kanghua Biotech Co.,Ltd Company Detail
    Table 108. Weifang Kanghua Biotech Co.,Ltd Business Overview
    Table 109. Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 110. Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 111. Weifang Kanghua Biotech Co.,Ltd Recent Development
    Table 112. CapitalBio Company Detail
    Table 113. CapitalBio Business Overview
    Table 114. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 115. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 116. CapitalBio Recent Development
    Table 117. BGI Company Detail
    Table 118. BGI Business Overview
    Table 119. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
    Table 120. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024) & (US$ Million)
    Table 121. BGI Recent Development
    Table 122. Research Programs/Design for This Report
    Table 123. Key Data Information from Secondary Sources
    Table 124. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type: 2023 VS 2030
    Figure 3. Mycoplasma Pneumoniae Features
    Figure 4. Streptococcus Pneumoniae Features
    Figure 5. Haemophilus Influenzae Features
    Figure 6. Moraxella Catarrhalis Features
    Figure 7. Chlamydia Pneumoniae Features
    Figure 8. Klebsiella Pneumoniae Features
    Figure 9. Staphylococcus Aureus Features
    Figure 10. Others Features
    Figure 11. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 12. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application: 2023 VS 2030
    Figure 13. Infant (<1 year old) Case Studies
    Figure 14. Children and Adolescents (1-25 years old) Case Studies
    Figure 15. Adult (25-65 years old) Case Studies
    Figure 16. Senior citizens (over 65 years old) Case Studies
    Figure 17. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Report Years Considered
    Figure 18. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 19. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region: 2023 VS 2030
    Figure 21. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players in 2023
    Figure 22. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2023)
    Figure 23. The Top 10 and 5 Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2023
    Figure 24. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2019-2030)
    Figure 26. United States LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2019-2030)
    Figure 30. Germany LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2019-2030)
    Figure 38. China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Australia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2019-2030)
    Figure 46. Mexico LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Brazil LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2019-2030)
    Figure 50. Turkey LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 53. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 54. Eiken Chemical Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 55. Deaou Biotechnology Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 56. Singuway Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 57. New England Biolabs Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 58. Lucigen Corporation Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 59. Merck Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 60. Mast Group Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 61. OptiGene Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 62. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 63. Weifang Kanghua Biotech Co.,Ltd Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 64. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 65. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Structural Health Monitoring (SHM) Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38Q3947
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Rapid Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-10A6230
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Anatomic Pathology Track and Trace Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18J7979
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Electroceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5K6273
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions